Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX.

medac Gesellschaft f��r klinische Spezialpr��parate mbH researches, develops, and manufactures medicinal products used for the treatment of oncological, urological, and autoimmune diseases. It also offers therapeutic agents for rheumatic, gastrointestinal, and dermatological autoimmune diseases. The company was founded by Wilfried Mohr in April 1970 and is headquartered in Wedel, Germany.

Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy.

Med Discovery is a Swiss biopharmaceutical company dedicated to the clinical development of highly specific treatments for cancers including uro-genital. To achieve this they are leveraging an in-house expertise in innovative biologics combined with an international network in clinical urology and oncology. Using this approach, Med Discovery intends to become a significant player in the uro-genital and oncology fields, developing products both in-house and with appropriate partners.

Biosafe SA operates as a medical technology company. It provides automated adult stem cell processing services. The firm specializes in the field of adult stem cell therapy, serving stem cell banks, hospitals and research institutes. The company was founded by Claude Fell and Lia Fell-Zakrajsek in 1997 and is headquartered in Eysins, Switzerland.

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Leibniz Institute for Polymer Research Dresden provides research and analysis services by incorporating state-of-the-art technology.

Glykos Finland Oy develops and manufactures drugs. The firm manufactures gene based medicines, diagnostic products and vector development for clinical experiments. It provides research on cancer glycomics, stem cell research and functional food. The company is located in Helsinki, Finland.

Zhejiang Puhui Medical Technology Co., Ltd., established on 2019-01-18, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Health Care Services(non-medical);hospital management;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:medical service;Health food production;Drug Wholesale;pharmaceutical production;Health food sales;Drug import and export;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

IPMBiotech focuses on the development and application of precision medical technology and cell therapy technology.

HLI Cellular Therapeutics LLC provides therapeutics services. The company is headquartered in San Diego, CA.

Horiba Ltd. engages in the manufacture and sale of instruments and systems for industrial applications. It operates through the following segments: Automotive Test Systems, Process and Environmental Instruments and Systems, Semiconductor Instruments and Systems, Medical-Diagnostic Instruments and Systems, and Scientific Instruments and Systems. The Automotive Test Systems segment sells emission measurement systems, automotive emission analyzers, onboard emission measurement systems, driveline test systems, engine test systems, break test systems, and drive recorders. The Process and Environmental Instruments and Systems segment manufactures stack gas analyzers, water quality analysis and examination systems, air pollution analyzers, and environmental radiation monitor. The Semiconductor Instruments and Systems segment includes mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, and residual gas analyzers. The Medical-Diagnostic Instruments and Systems segment offers equipment for blood sample analysis. The Scientific Instruments and Systems segment sells particle-size distribution analyzers, x-ray fluorescence analyzers, Raman spectrophotometers, gratings, and pH meters. The company was founded by Masao Horiba on October 17, 1945 and is headquartered in Kyoto, Japan.

Mirae Biotech Co. Ltd. is a South Korean private company located in Seoul. The firm operates as a bio technology research company.

Green Cross Co., Ltd. engages in the manufacture, sale, and rental of safety items. Its products include road safety materials, disaster prevention necessities, safety equipment, protection gear, and signboards and tags. The company was founded in January 1969 and is headquartered in Fukuoka, Japan.

Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.